[1]. Snoeck Henkemans S, de Jong P, Luime J, Kok M, Tchetverikov i, van der Helm-van Mil A, vis m. The Window of Opportunity in Psoriatic Arthritis: Similar to Rheumatoid Arthritis? [abstract]. Arthritis Rheumat...
[1]https://acrabstracts.org/abstract/febuxostat-dose-requirement-for-achieving-target-serum-urate-levels-according-to-renal-function-a-retrospective-cohort-study/.Accessed November 7,2023. [2]Baraf H,Kivitz A,Rhodes S,Leung S,Folarin O,Gonzalez-Rivera T,Sobierska J,Christie J,Patel A,DeHaan...
[6]Chen C, et al. Incidence, Risk Factors, and Outcomes of Severe Lymphopenia in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/incidence-risk-factors-and-outco...
[1]https://acrabstracts.org/abstract/systemic-lupus-erythematosus-b-lymphocyte-responsiveness-to-type-i-and-type-iii-interferon-is-determined-by-donor-ifn-status-and-b-cell-phenotype.(2023.11.12) [2]https://acrabstracts.org/abstract/elevated-line-1-expression-in-sle-keratinocytes-leads-to-line-...
[11]Fan C, et al. Interferon-stimulated Genes on Peripheral CD8+ T Cells of SLE Patients Were the Keys for Early Response to BAFF/APRIL-targeted Therapy [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/interferon-stimulated-genes-on-peripheral-cd8-tcell...
Abstracts not accepted in the main abstract review submission should not be re-submitted to the late-breaking category. 注册费: ACR Convergence 2023, the world’s premier rheumatology experience, will be held November 10–15 at the San Diego Convention Center in San Diego, California. ...
Abstract Supplement ACR Convergence 2023CALIFORNIAUNITED StatesRHEUMATOLOGYCONFERENCES & conventionsINFORMATION resourcesFor a searchable version of these abstracts, please visit www.acrabstracts.org.doi:10.1002/art.42700Wiley Periodicals, Inc.Arthritis & Rheumatology...
Always proofread your abstract. Accepted abstracts will be published exactly as submitted. ePosters must give a balanced view of therapeutic options. Brand names of pharmaceuticals and trade names of medical devices cannot be used in the title or body of the abstract. The ACR reserves the right ...
Always proofread your abstract. Accepted abstracts will be published exactly as submitted. ePosters must give a balanced view of therapeutic options. Brand names of pharmaceuticals and trade names of medical devices cannot be used in the title or body of the abstract. The ACR reserves the right ...
2.https://acrabstracts.org/abstract/effect-of-secukinumab-VSersus-adalimumab-biosimilar-onradiographic-progression-in-patients-with-radiographic-axial-spondyloarthritis-arandomized-phase-iiib-study/. Accessed March 15, 2023. 3.Michael M Ward, et al. Arthritis Rheumatol. 2019 Oct;71(10):1599-1613....